Whitehawk director receives 38,040 WHWK stock options
Whitehawk Therapeutics director Emma Reeve received a stock option grant, giving her the right to buy 38,040 shares of common stock at an exercise price of $4.16 per share.
Rhea-AI Filing Summary
Whitehawk Therapeutics director Emma Reeve received a stock option grant, giving her the right to buy 38,040 shares of common stock at an exercise price of $4.16 per share. The option was granted as a compensation award with no cash paid at grant.
The option expires on June 12, 2036. All 38,040 shares subject to the option vest 100% on the earlier of one year after the June 12, 2026 grant date or the day immediately before the next annual stockholder meeting, as long as she continues as a service provider. Following this grant, she holds options covering 38,040 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 38,040 shares
Grant/Award
1 txn
Insider
Reeve Emma
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 38,040 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 38,040 contracts (Direct)
Footnotes (1)
- F1. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2026.
Key Figures
Option grant size: 38,040 shares
Exercise price: $4.16 per share
Expiration date: June 12, 2036
+2 more
5 metrics
Option grant size
38,040 shares
Stock Option (right to buy) underlying common stock
Exercise price
$4.16 per share
Conversion or exercise price of stock option
Expiration date
June 12, 2036
Option expiration for the reported grant
Total options after grant
38,040 shares
Total derivative shares following transaction, held directly
Vesting condition
100% cliff vesting
Vests on earlier of one-year from grant or before next annual meeting, with continued service
Key Terms
Stock Option (right to buy), Equity Incentive Plan, Service Provider, vest, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Equity Incentive Plan financial
"Issuer's 2021 Equity Incentive Plan referenced in vesting footnote"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Service Provider financial
"Subject to the Reporting Person continuing to be a Service Provider"
vest financial
"one hundred percent (100%) of the shares subject to the option shall vest"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Whitehawk Therapeutics (WHWK) director Emma Reeve report on this Form 4?
Emma Reeve reported receiving a grant of stock options to acquire 38,040 shares of Whitehawk Therapeutics common stock. The award is a compensation-related grant, not an open-market purchase, and is structured as a derivative security giving future purchase rights at a fixed exercise price.
What is the exercise price and expiration date of Emma Reeve’s WHWK stock options?
The options have an exercise price of $4.16 per share and expire on June 12, 2036. This means Reeve can buy up to 38,040 shares at $4.16, once vested, any time before the expiration date, assuming continued eligibility under the plan.
How and when do Emma Reeve’s Whitehawk Therapeutics options vest?
All 38,040 option shares vest 100% on the earlier of the one-year anniversary of the June 12, 2026 grant date or the day immediately before the next annual stockholder meeting. Vesting requires that she continue as a service provider through the applicable vesting date.
Is Emma Reeve’s Form 4 transaction a market purchase of WHWK stock?
No, the filing shows a grant of stock options as compensation, coded as a grant, award, or other acquisition. No shares were bought in the open market, and the transaction price per option at grant was reported as $0.00 per share.
What is Emma Reeve’s derivative holdings in WHWK after this option grant?
After the transaction, Reeve directly holds stock options covering 38,040 shares of Whitehawk Therapeutics common stock. This reflects the full size of the reported award, as indicated by the total derivative shares following the transaction on the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
